Tag: university of witwatersrand

Oxford & AstraZeneca COVID-19 vaccine trials halted for safety review

One of the most promising COVID-19 vaccine trials has been halted; after one of its U.K participants developed a “potentially unexplained illness”. The vaccine was developed by the University of Oxford in partnership with AstraZeneca, and is currently being trialled in South Africa, Brazil, the UK and the US. Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand joins CNBC Africa for more.

How close is SA to a COVID-19 vaccine?

This week the Unites Stated and the UK have had encouraging updates of their respective Covid-19 vaccine trials, showing promising results which could see a vaccine available as early next year. Back home in South Africa, we are about a month into our vaccine trial and the country is experiencing volatile surges in case numbers, will this be a threat to the progress of the vaccine trial? Joining CNBC Africa for more is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.

Professor Shabir Madhi gives update on SA’s first COVID-19 vaccine trials

It’s been almost three weeks since South Africa’s first COVID-19 vaccine trials began, we will be unpacking more on the progress of these trials as well as the latest emerging evidence brought to the attention of the World Health Organization regarding the airborne transmission of COVID-19. Joining CNBC Africa for more is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.

SA’s first COVID-19 vaccine trial to start tomorrow

The University of Witwatersrand in conjunction with leading health experts have announced the details of South Africa’s and Africa’s first COVID-19 vaccine trials. Joining CNBC Africa for more is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.

Understanding SA’s role in the race to find COVID-19 vaccine

The race for a Covid-19 vaccine has begun as the U.K and U.S have already started working on the first batches of vaccine trials. But the rest of the world is not far behind in vaccine research either as earlier this week South Africa’s health minister Zweli Mkhize pronounced that the country’s participation in the Public Health Emergency Solidarity Trial created by the World Health Organisation. Mkhize stated that participation in the trials benefit South Africa from being at the forefront of accessing approved vaccines and adding our expertise to the global body of knowledge around Covid-19. Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand joins CNBC Africa for more.
Advertisment